Alopecia areata;Alopecia areata

Hautarzt

Volumn 50, Issue 3, 1999, Pages 222-231

  Hoffmann, R ^a   Happle, R ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALOPECIA AREATA; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; GERMANY; HUMAN; REVIEW; ADULT; AGED; ANIMAL; C3H MOUSE; FEMALE; HAIR; IMMUNOTHERAPY; MALE; MIDDLE AGED; MOUSE; PATHOLOGY; PROGNOSIS; SKIN;

ADULT; AGED; ALOPECIA AREATA; ANIMALS; FEMALE; HAIR; HUMANS; IMMUNOTHERAPY; MALE; MICE; MICE, INBRED C3H; MIDDLE AGED; PROGNOSIS; SKIN;

EID: 0033094037     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001050050895     Document Type: Review

References (38)

1. Ahmad W, Faiyaz ul Haque M, Brancolini V, Tsou HC, ul Haque S, Lam H, Aita VM, Owen J, deBlaquiere M, Frank J, Cserhalmi-Friedman PB, Leask A, McGrath JA, Peacocke M, Ahmad M, Ott J, Christiano A (1998) Alopecia universalis associated with a mutation in the human hairless gene. Science 279:720-724
2. Ashworth J, Tuyp E, Mackie R (1989) Allergic and irritant contact dermatitis compared in the treatment of alopecia totalis and universalis. A comparison of the value of topical diphencyprone and tretinoin gel. Br J Dermatol 120:397-401
3. Baar HMJ van, Vleuten CJM van der, Kerckhof PCM van de (1995) Dapsone versus topical immunotherapie in alopecia areata. Br J Dermatol 133:270-274
4. Becker JC, Varki N, Bröcker EB, Reisfeld RA (1996) Lymphocyte-mediated alopecia in C57/BL/6 mice following successful immunotherapy for melanoma. J Invest Dermatol 107:627-632
5. Bröcker EB, John SM, Steinhausen D, Hamm H (1991) Topical immunotherapy with contact allergens in alopecia areata: evidence for non-specific systemic suppression of cellular immune reactions. Arch Dermatol Res 283:133-134
6. Colon EA, Popkin MK, Callies AL,Desser NJ, Hordinsky MK (1991) Lifetime prevalence of psychiatric disorders in patients with alopecia areata. Compr Psychiatry 32:245-251
7. De Groot A, Nater JP, Bleumink E, de Jong MSJM (1981) Does DNCB potentiate epicutaneous sensitization to non-related allergens? Clin Exp Dermatol 6:139
8. Dressel D, Boehncke WH (1997) Alopecia areata but not androgenetic alopecia is characterized by a restricted and oligoclonal T-cell receptor repertoire among infiltrating lymphocytes. J Cutan Pathol 24:1-7
9. Egle UT, Tauschke E (1987) Die Alopezie, ein pychosomatisches Krankheitsbild? Psychother Med Psychol 37:31-38
10. Galbraight GM, Miller D, Emerson DL (1988) Western blot analysis of serum antibody reactivity with human melanoma cell antigens in alopecia areata and vitiligo. Clin Immunol Immunopathol 48:317-324
11. Galbraight GM, Pandey JP (1995) Tumor necrosis factor alpha (TNF-alpha) gene polymorphism in alopecia areata. Hum Genet 96:433-436
12. Gilhar A, Pillar T, Assay B, David M (1992) Failure of passive transfer of serum from patients with alopecia areata and alopecia universalis to inhibit hair growth in transplants of human scalp grafted onto nude mice. Br J Dermatol 126:166-171
13. Gilhar A, Ullmann Y, Berkutzki T, Assy B, Kalish RS (1998) Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice. J Clin Invest 101:62-67
14. Gollnick H, Orfanos CE (1990) Alopecia areata: pathogenesis and clinical picture. In: Orfanos CE, Happle R (eds) Hair and hair diseases. Springer, Berlin, pp 529-569
15. Happle R, Hausen BM, Wiesner-Menzel L (1983) Diphencyprone in the treatment of alopecia areata. Acta Derm Venereol (Stockh) 63:49-52
16. Happle R, van der Steen PHM, Perret CM (1991) The Renbök phenomenon: an inverse Köbner reaction observed in alopecia areata. Eur J Dermatol 2:39-40
17. Hoffmann R, Wenzel E, Huth A, Steen PHM van der, Schäufele M, Henninger HP, Happle R (1994) Cytokine mRNA-levels in alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone. J Invest Dermatol 103:530-533
18. Hoffmann R, Huth A, Wenzel E, Steen PHM, Schäufele M, Raykowski S, Happle R (1996) T-cell receptor Vb chain variable gene use in alopecia areata totalis. Eur J Dermatol 6:65-69
19. Hoffmann R, Eicheler W, Huth A, Wenzel E, Happle R (1996) Cytokines and growth factors influence hair growth in vitro: possible implications for the pathogenesis and treatment of alopecia areata. Arch Dermatol Res 288:153-156
20. Hoffmann R, Happle R (1996) Alopecia areata: Aktuelles über Ätiologie, Pathogenese, Klinik und Therapie. Z Hautkr 71:528-541
21. Khoury EL, Price V (1995) No cell-surface-reactive antibodies against cultured autologous melanocytes found in alopecia areata sera. J Invest Dermatol 104:24S
22. McElwee KJ, Spiers EM, Oliver RF (1995) In vivo depletion of CDS+ T cells restores hair growth in the the DEBR model for alopecia areata. Br J Dermatol 135:211-217
23. McElwee KJ, Ruthton DH, Trachy R, Oliver RF (1997) Topical FK506: a potent immunotherapy for alopecia areata? Studies using the Dundee experimental bald rat model. Br J Dermatol 137:491-497
24. Muller SA, Winkelmann RK (1963) Alopecia areata: an evaluation of 736 patients. Arch Dermatol 88:290-297
25. Paus R, Slominski A, Czarnetzki BM (1993) Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in anagen hair bulb? Yale J Biol Med 66:541-554
26. Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ (1995) Incidence of alopecia areata in Olmsted county, Minnesota, 1975 through 1989. Mayo Clin Proc 70:628-633
27. Steen PHM van der, Boezeman JBM, Happle R (1992) Topical immunotherapy for alopecia areata: Re-evaluation of 139 cases after an additional follow-up period of 19 months. Dermatology 184:198-201
28. Steen PHM van der, Boezeman J, Duller P, Happle R (1992) Can alopecia areata be triggered by emotional stess? An uncontrolled evaluation of 178 patients with extensive hair loss. Acta Derm Venereol (Stockh) 72:279-280
29. Stewart MI, Smoller BR (1993) Alopecia universalis in an HIV-patient: possible insight into pathogenesis. J Cutan Pathol 20:180-183
30. Stricker RB, Goldberg B, Mills BL, Epstein WL (1995) Improved results of delayed-type hypersensitivity skin testing in HIV-infected patients treated with topical dinitrochlorobenzene. J Am Acad Dermatol 33:608-611
31. Sundberg JP, Cordy WR, King LE (1994) Alopecia areata in aging C3H/HeJ mice. J Invest Dermatol 102:847-856
32. Tarlow JK, Clay FE, Cork MJ, Blakemore AIF, McDonagh AJG, Messenger AG, Duff GW (1994) Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene. J Invest Dermatol 103:387-390
33. Tobin DJ, Orentreich N, Fenton DA, Bystryn JC (1994) Antibodies to hair follicles in alopecia areata. J Invest Dermatol 102:721-724
34. Valsecchi R, Cainelli T (1985) Nickel sensitivity as a complication of squaric acid dibutylester treatment of alopecia areata. Contact Dermatitis 12:466
35. Walker AS, Rothman S (1950) Alopecia areata: A statistical study and consideration of endocrine influences. J Invest Dermatol 14:403-413
36. Weise K, Kretzschmar L, John SM, Hamm H (1996) Topical immunotherapy in alopecia areata: anamnestic and clinical criteria of prognostic significance. Dermatology 192:129-133
37. Whittemore AS, Holly EA, Lee IM, Abel EA, ADAMS IRM, Nickoloff BJ, Peters JM, Gibney C (1989) Mycosis fungoides in relation to environmental exposures and immune response: a case control study. J Natl Cancer Inst 81:1560-1567
38. Ziegler V, Ziegler B (1994) Experimentally induced malignant lymphoma due to chronic antigen stimulation. Contact Dermatitis 30:77-79